A recent study in Sierra Leone has underscored the importance of strategic outreach in promoting the use of HIV prevention medication, particularly the long-acting injectable medication known as LEN. The study found that nearly half of those surveyed, 46%, learned about the medication through targeted outreach efforts, such as conversations with healthcare professionals and social media campaigns. This highlights the need for a proactive approach to creating awareness and demand for the medication.
The study also revealed that peer educators played a crucial role in promoting the use of HIV prevention medication. Projects that employed peer educators to engage potential users were particularly successful, with around 46% to 50% of participants starting to take the medication immediately after learning about it. In contrast, initiatives without peer educators had lower success rates, with only 21% to 34% of participants starting treatment. This suggests that the credibility of the messenger is essential in promoting the use of HIV prevention medication.
The study further emphasized the importance of swift action in promoting the use of HIV prevention medication. Peer navigators not only provided information but also guided individuals on how to access the medication, reducing delays and increasing the likelihood of uptake. The study noted that delays in accessing treatment can result in wasted opportunities, highlighting the need for seamless connections between outreach efforts and clinics.
The study also examined the role of mass media in promoting HIV prevention medication. However, the findings suggest that mass media may not be an effective tool in persuading people to use the medication. Only 5% of young respondents reported learning about HIV prevention through traditional media, while 84% heard about it through friends, family, healthcare professionals, or targeted online platforms.
The study highlighted the need for policymakers to recognize the costs associated with creating demand for HIV prevention medication. Activities aimed at raising awareness accounted for 14% to 40% of total costs per HIV prevention visit, depending on the strategy and outreach scope. Health budgets typically prioritize direct costs, such as medicines and nurse training, but the study emphasizes the need for provisions for demand creation.
Effective evaluation of demand-creation campaigns is also crucial, according to the study. Measuring mere attendance at events or impressions on social media provides little insight into campaign success. Instead, the study suggests that the health department should monitor the effectiveness of different outreach strategies, enabling a shift of funds towards successful methods and away from less effective ones.
The study's findings have important implications for the rollout of HIV prevention medication in Sierra Leone. To ensure a successful rollout, governmental budgets must include provisions for demand creation, not just the purchase of LEN and training for healthcare providers. The study's insights can inform the development of effective outreach strategies, ultimately increasing the use of HIV prevention medication and reducing the risk of HIV transmission.
Key points
- The credibility of the messenger is crucial in promoting the use of HIV prevention medication.
- Swift action is essential in promoting the use of HIV prevention medication, reducing delays and increasing the likelihood of uptake.
- Effective evaluation of demand-creation campaigns is crucial to ensure that funds are allocated to successful strategies.
